Market Signal Briefing

One is going to appeal to more investors than the other.

Costco Wholesale (COST 0.23%) and Coca-Cola (KO +0.13%) are both reliable long-term performers. Right now, however, the two stocks are heading in vastly different directions. Costco is trending lower, off from its 52-week high by around 15%. Coca-Cola is trending higher, below its all-time highs by just 3% or so.

Here's why more investors will probably prefer Coca-Cola right now.

Coca-Cola beats Costco as a dividend stock
Even after the recent drawdown in Costco's share price, it's still only offering a dividend yield of 0.6%. That's half the level of the S&P 500, and well below Coca-Cola's nearly 2.9% yield. Coca-Cola's yield is only about average for the soda maker in recent years, but it is a touch better than the 2.7% of the average consumer staples stock, using the Consumer Staples Select Sector SPDR ETF as an industry proxy.

Image source: Getty Images.

From a yield-only perspective, Coca-Cola is the winner. However, it also excels in dividend consistency, having increased its dividend annually for over six decades. That streak is enough to make it a Dividend King. While Costco is no slouch on the dividend front, with 21 annual dividend hikes behind it, it's still nearly three decades away from achieving Dividend King status.

Coca-Cola beats Costco as a value stock
When you examine the valuations of Coca-Cola and Costco, Coca-Cola again emerges as the top performer. Currently, Coca-Cola's price-to-earnings (P/E) and price-to-book value (P/B) ratios are both below their five-year averages. Its price-to-sales (P/S) ratio is roughly even with its five-year average.

In comparison, Costco's P/S, P/E, and P/B ratios are all above their five-year averages, despite the 15% decline in its stock price. From a valuation perspective, Costco looks expensive and Coca-Cola looks fairly priced to a little cheap.

Today's Change

(

0.13

%) $

0.09

Current Price

$

71.16

Costco beats Coca-Cola from a growth perspective
Dividend lovers and value investors will probably prefer Coca-Cola over Costco right now. However, growth and dividend growth investors may be tempted to opt for Costco. Coca-Cola's average annualized dividend growth over the past decade was a healthy 5% or so. However, Costco's is double that, with annualized dividend growth of approximately 12% over the past decade. The actual dividend is lower, but the dividend growth is way more attractive.

Looking simply at growth, Coca-Cola's revenue has essentially remained flat over the past decade, while its earnings rose by a little over 4% per year on an annualized basis. That's not hugely compelling, even though the company is still growing its earnings. Costco's revenue grew at an annualized rate of around 9% over the last decade, with its earnings expanding at a roughly 13% annualized clip.

Costco's growth story is a lot more interesting, as it benefits from opening new stores as it expands geographically. Coca-Cola, in comparison, has pretty well saturated the global beverage market. Modest, though slow and steady, earnings growth is probably the best you can expect.

Today's Change

(

-0.23

%) $

-2.10

Current Price

$

922.98

What's interesting about Costco today is that its shares are down approximately 15%. This is the seventh such drawdown over the past decade. Although the last drawdown went a lot further, pulling the stock down over 20% and into its own personal bear market, history indicates that Costco will eventually rebound and push to higher highs. If you think in decades, not days, Costco is probably an attractive growth stock, even if you end up paying a premium for the shares.

Coca-Cola is the better deal
Coca-Cola and Costco both operate good businesses, though they are drastically different companies. From a dividend investor's point of view and from the guise of a value investor, Coca-Cola is likely to be a more attractive investment than Costco today.

From a growth investing perspective, however, Costco emerges as the long-term winner. Just understand that you will pay a premium if you purchase the stock today. If that's not OK with you, then put it on your wishlist and hope that the current 15% price decline keeps going. If the drawdown reaches 20%, the stock might become a little more interesting.

This ETF is made up of many time-tested, high-quality companies.

One reason I'm a fan of dividend exchange-traded funds (ETFs) is that they combine two of my favorite parts of investing: guaranteed income and ETFs. Stock price appreciation is great and undoubtedly appreciated, but it's nice to own dividend stocks and know you'll get rewarded regardless of the stock's price movements.

And ETFs are great because they allow you to cover a lot of ground and check many investing boxes with just a few investments. Combine the two, and voilà -- you have an investment that can be rewarding and less risky than investing in individual stocks.

It doesn't require a significant amount of money to receive value from a dividend ETF, either. Even if you have less than $1,000 to invest, the following dividend ETF is a great option to consider adding to your portfolio.

Image source: Getty Images.

One of the best dividend ETFs on the market
If you're looking for a high-quality dividend ETF, look no further than Schwab U.S. Dividend Equity ETF (SCHD +0.07%). Mirroring the Dow Jones U.S. Dividend 100 index, SCHD has criteria that essentially act as a de facto vet for you. To be included in the ETF, a company must have at least 10 consecutive years of dividend payouts, a healthy balance sheet, and solid cash flow.

Below are some notable names included from different major sectors of the U.S. economy:

Energy (19.34% of the ETF): Chevron and ConocoPhillips
Consumer staples (18.50%): Coca-Cola and PepsiCo
Health care (16.10%): AbbVie and Merck
Industrials (12.28%): Lockheed Martin and United Parcel Service
Financials (9.37%): Fifth Third Bancorp and T. Rowe Price

When you invest in SCHD, you can be confident that you're investing in an ETF that contains a diverse portfolio of high-quality companies. Most of them are large-cap stocks, with 58% of the companies in SCHD having a market cap of over $70 billion.

Today's Change

(

0.07

%) $

0.02

Current Price

$

27.24

A dividend yield worth paying attention to
When looking at the upper tier of dividend ETFs, SCHD has one of the higher dividend yields out there. At the time of this writing, its yield is 3.8%, which is three times higher than the S&P 500 average. It's also slightly higher than its average for the past five years.

Dividend yields fluctuate with stock prices, but over the past couple of years, SCHD has consistently had a yield that's higher than many S&P 500 dividend stocks and the S&P 500 itself.

A great way to approach investing in SCHD
If you invest $1,000 into SCHD and it maintains a 3.8% yield (which it won't, but we'll assume so for the sake of illustration), it would pay out $38 annually. This isn't life-changing money by any means, so it can often be more impactful if you reinvest the dividends to acquire more shares.

Most brokerage platforms offer a dividend reinvestment plan (DRIP), which automatically reinvests the dividends you receive in additional shares of the stock or ETF that paid them. This makes the process seamless, operating behind the scenes. Ideally, you'd keep reinvesting the dividends for more shares until you've acquired enough to receive a decent amount whenever you decide to begin receiving cash payouts.

Over the past decade, SCHD has averaged 11.3% total annual returns. With an 11% annual average, a single $1,000 investment would grow to just over $8,000 in 20 years, which would then pay out around $300 annually with a 3.8% yield. If you added $100 monthly, it would grow to around $85,100, paying out over $3,200 annually.

SCHD data by YCharts

The specific dollar figures will obviously vary based on returns, but this example shows how powerful compound earnings can be, especially regarding dividends and taking advantage of your brokerage platform's DRIP. The Schwab U.S. Dividend Equity ETF has all the tools (and holdings) to be a great long-term investment. The key is patience.

Last week, I noted how December is typically a great time to buy stocks.  

Holiday shopping and corporate “use it or lose it” budgets mean that retailers and enterprise software firms alike see their highest sales during this period. It’s also a time for managers to “window dress” corporate results to meet year-end goals. 

Since the 1950s, markets have ended December higher 75% of the time. 

Markets are also entering this year-end with wind in their sails (and sales). Despite this week’s selloff, the S&P 500 has still risen 15% this year on strong corporate earnings. History tells us that strong earnings momentum typically carries into future months. 

However, the excitement could trigger a nasty hangover for 2026. 

Over the past two White House administrations, we’ve seen valuations get crushed in Year 2 after the excitement of a new president wears off. That’s when the economic realities of executive agendas begin to take effect, and markets lose their glow. Below is a graph of the S&P 500’s cyclically adjusted P/E ratio (CAPE) from the past two presidential terms: 

That pullback in valuations dragged the market down in the past two midterm years, despite earnings rising 6% in each: 

 Trump 1 Biden 1 Trump 2 Year 1 19.4% 26.9% 14.4% Year 2 -6.2% -19.4% ? Year 3 28.9% 24.2%  Year 4 16.3% 23.3%  
In fact, if you examine data dating back to 1928, it turns out that stocks in Year 2 of a presidential term have returned just 3.3% on average, compared to 9.7% return from other years. Data from U.S. Bank finds that this 3.3% figure turns negative if you start counting November-to-November results from the 1960s onward.  

The hangover from America’s election cycle is quite real. 

I should note that there are other reasons to be cautious about markets in 2026. 

Narrow Growth. U.S. growth is becoming increasingly concentrated among a small number of AI firms. Louis Navellier notes that investment in data centers and related AI technologies accounted for 92% of U.S. GDP growth in the first half of 2025. This is starving other capital-intensive sectors of cash; real estate, healthcare, energy, and financials have seen their 2026 earnings estimates get slashed by 10% or more over the past two months, according to FactSet.  

Consumers. Consumer confidence is hitting new lows. In October, the University of Michigan survey of consumer sentiment hit its lowest reading on record. PwC’s holiday outlook for 2025 calls for an 11% decline in average gift spending, driven by a 23% drop in Gen Z spending and “trading down” across the board.  

Layoffs. Perhaps most worryingly, we’re beginning to see another 2022-style “year of efficiency” round of layoffs, where large corporations cut headcounts to save costs. On October 28, Amazon.com Inc. (AMZN) announced that it would cut 14,000 corporate jobs (not just frontline workers) to save between 3% and 5% in overhead costs. Verizon Communications Inc. (VZ) announced a 15,000-person cut this week, which would eliminate 15% of its workforce. 

These are not the kind of moves you see in a booming market. 

Fortunately, “smart money” buyers still see value in certain corners of the market. Last week, I introduced three firms that have seen strong insider buying; the value-based trio has risen by a percentage in the past week (despite a drop in the S&P 500) and should continue to move higher as investors seek safe havens.  

This week, I’ll leave you with two more that should do the same. 

However, before I do that, there’s something even more important I need to highlight: 

Investors with neutral market exposure have done even better. And you can too. 

The Market-Neutral Trader 
Over the past three weeks, our trading expert, Jonathan Rose, has closed out several impressive winners, including trades on: 

Viasat Inc. (VSAT). +158%  
Bitmine Immersion Technologies Inc (BNMR). +73% 
Qorvo Inc (QRVO). +283% 

These gains were possible because Jonathan’s approach doesn’t rely on markets rising or falling. Instead, his strategy takes a neutral stance on markets and profits from volatility instead. 

Jonathan does this by using a system that identifies periods when large institutional investors inadvertently “tip their hand.” In calm markets, billion-dollar block trades are easier to mask. However, when volatility increases, these trades become more apparent in the data. It’s also when big players start making mistakes in their haste to move large sums of money. 

By analyzing these tells, Jonathan can spot when major buy or sell orders are being queued up, allowing him and his readers to take action before these moves fully play out. If a million-dollar order can push a mid-cap stock up by $1 to $2… imagine the impact of a billion-dollar order hitting the tape. 

This trading strategy will become even more important heading into 2026, as rising uncertainty and tighter consumer conditions increase volatility and expand the opportunity set for market-neutral strategies like Jonathan’s. 

To explain this all, Jonathan teamed up with Louis Navellier, Eric Fry, and Luke Lango last week for a special Profit Surge Event. In this free presentation, the four explained how Jonathan’s system works in both good times and bad by detecting buying and selling pressures by large players. 

But that’s not all. Jonathan also showed how applying a simple tweak can multiply the payoff by 500% or more. 

If you missed it, don’t worry. You can still catch a replay here to see how Jonathan and our other Senior Analysts view the current market environment – and show you how to sharpen your strategy for the final stretch of 2025. 

Until then, let’s get back to those two more stocks that should hold up even if investors start paying less for every dollar of earnings in 2026. 

Two More Stocks to Buy for a Volatile 2026 
The first pick this week is Bloomin’ Brands Inc. (BLMN), the owner of Outback Steakhouse, Carrabba’s Italian Grill, Bonefish Grill, and Fleming’s Prime Steakhouse. Last week, the company saw a massive insider purchase by its chief financial officer of 150,000 shares for $6.38 per share. A director also added 1,500 shares to their retirement account. 

These mark the first insider purchases since Bloomin’ CEO Mike Spanos acquired 118,000 shares in March 2025, after “Liberation Day” tariffs sent BLMN below $10 for the first time since the 2020 Covid-19 pandemic. (Spanos was sitting on 20%-plus gains by July.) 

Today’s buys are being made at an even more compelling valuation. Shares are trading below 6X forward earnings (compared to their long-term average of 12X) and 2X price-to-cashflow (less than half of their 5.4X average). Bloomin’ is still a profitable company, even if earnings are somewhat diminished from their post-Covid peak. 

In addition, the company’s turnaround strategy is starting to show results. On November 6, management announced that comparable store sales growth had turned positive at all four brands for the first time since fist quarter 2023. This turnaround strategy involves simplifying menus, running ad campaigns, and pursuing a “barbell” strategy that offers low-priced options in addition to premium items.  

Outback’s Aussie 3-Course Meals, for example, now start at just $14.99, making it competitive with many fast-food chains. 

Now, Bloomin’ is obviously coming from a relatively low starting point. Diners have soured on midrange restaurants this year, and even Brinker International Inc. (EAT), the owner of high-growth chain Chili’s, has seen its shares stagnate. (Chili’s saw massive success pursuing a barbell strategy last year.) 

Nevertheless, Bloomin’s low valuations give plenty of room for things to go wrong. And if its CFO is correct, we could see shares rise 100% in 2026 as markets pivot back toward low-priced value stocks. 

The second firm this week with notable insider buying is Mosaic Co. (MOS), one of the largest U.S.-based fertilizer companies. 

As Eric noted in late 2022 in a Fry’s Investment Report update (subscription required), the fertilizer market was upended that year by Russia’s invasion of Ukraine. Prices initially surged on panic buying, and then collapsed as supplies began to normalize. This presented investors with an unusual array of options in commodity-related picks. 

Now, opportunity is knocking once again. Shares of commodity-related companies have declined on fears of a new U.S.-China trade war, and Mosaic’s stock has now fallen by a third since July. 

The selloff makes little sense. According to data from the Bureau of Labor Statistics, producer prices have actually marched higher since mid-2023, a positive sign for Mosaic’s future profits. Potash, the largest contributor to Mosaic’s profits, has seen prices rise from below $300 per metric ton in January to $352 today. 

Some smart money buyers might be catching on. Mosaic’s quantitative “follow-the-money” score, according to Louis Navellier’s Stock Grader, has also risen from a rock-bottom “F” to a more reasonable “C.” Then on November 13, a director made the first “informed buy” by a Mosaic insider in more than three years.Most importantly, Mosaic presents a compelling value play in an industry that’s relatively devoid of them. Potash is an essential ingredient in farming, and record crop yields in the U.S. and Brazil mean that farmers will need to replenish their soil for the 2026 planting season.  

If potash prices stay in the mid-$300 range, MOS is worth roughly $35, a 40% upside. Even if the S&P 500 price-to-earnings ratio begins to fall, Mosaic’s attractive 9X multiple gives it plenty of room for error. 

Getting Ready for a Rough 2026 
By any measure, last week should have been a great one for stock markets. 

The U.S. government reopened… 
The Trump administration cut tariffs to reduce food prices… 
Alternative data suggested U.S. inflation remained muted in October… 

Yet, all three major U.S. stock indexes saw a terrible selloff this week after… well… not much. When valuations are so high, it only takes a tiny price drop to trigger a landslide of panic selling by institutional investors. 

That’s what we’re seeing now. Smart money investors are selling, while retail traders are holding out for a recovery. (Popular meme stocks like Opendoor Technologies Inc. [OPEN] have not faced as much of a selloff.) 

To navigate this market, I encourage you to watch our replay of Jonathan’s Profit Surge Event, where he and our three analysts go deep on how to trade this increasingly volatile market. The Santa Claus rally might still happen… but markets could be due for a nasty eggnog hangover in 2026. 

But don’t wait long. The deadline for watching this replay is Monday night. 

Until next week, 

Tom Yeung, CFA 

Market Analyst, InvestorPlace 

Thomas Yeung is a market analyst and portfolio manager of the Omnia Portfolio, the highest-tier subscription at InvestorPlace. He is the former editor of Tom Yeung’s Profit & Protection, a free e-letter about investing to profit in good times and protecting gains during the bad.

, /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Stride, Inc. ("Stride" or "the Company") (NYSE: LRN) and certain of its officers.

Class Definition

This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Stride securities between October 22, 2024 and October 28, 2025, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/LRN.

Case Details

The Complaint alleges that throughout the Class Period, Defendants made misleading statements and omissions regarding the Company's products and services to public and private schools, school districts, and charter boards. Specifically, the Complaint alleges that: (1) Stride represented to investors that "[t]hese products and services, spanning curriculum, systems, instruction, and support services are designed to help learners of all ages reach their full potential through inspired teaching and personalized learning;" and (2) Unbeknownst to investors Stride was: (a) inflating enrollment numbers by retaining "ghost students"; (b) cutting staffing costs by assigning teachers' caseloads far beyond the required statutory limits; (c) ignoring compliance requirements, including background checks and licensure laws for its employees, and ignoring federally mandated special education services to students; (d) suppressing whistleblowers who documented financial directives from Stride's leadership to delay hiring and deny services to preserve profit margins; and (e) losing existing and potential enrollments.

What's Next?

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm's site: bgandg.com/LRN. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 332-239-2660. If you suffered a loss in Stride you have until January 12, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.

There is No Cost to You

We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.

Follow us for updates on LinkedIn, X, Facebook, or Instagram.

Attorney advertising. Prior results do not guarantee similar outcomes.

Contact

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Nathan Miller
332-239-2660 | [email protected]

SOURCE Bronstein, Gewirtz & Grossman, LLC

Investors will be watching what Trump makes happen.

Don't look now, but the costs of America's beloved weight loss drugs are about to come down. Way down. At least, that's the promise of a deal reached in early November between the Trump administration and pharmaceutical companies Novo Nordisk (NYSE: NVO) and Eli Lilly (LLY +0.34%).

Under its terms, those products will be sold by their developers through a planned national online drug platform called TrumpRx at a steep discount to certain current rates (under agreements set with said developers). That sounds beneficial to consumers, but whether it'll boost the fortunes of the affected drugmakers is another question. 

The two heavyweights of weight loss
This particularly affects the two leading Food and Drug Administration (FDA)-approved GLP-1 treatments indicated purely for weight loss -- Novo Nordisk's Wegovy and Zepbound from Eli Lilly.

Image source: Getty Images.

Since being approved, Wegovy's popularity has soared, to the point where the drug has made its maker, Novo Nordisk -- for decades a fairly under-the-radar Danish healthcare company -- a well-recognized name. Regarding Eli Lilly's Zepbound, sales of the drug just keep climbing, from just over $517 million in the initial quarter after approval (first quarter of 2024), to nearly $3.6 billion in the third quarter of this year.

Today's Change

(

-1.83

%) $

-0.90

Current Price

$

48.26

A recently published survey conducted by researcher Gallup found that the percentage of respondents answering "yes" to the question "Have you ever taken an injection for weight loss?" more than doubled from the first calendar quarter of 2024 to the second and third quarters of 2025 (from 5.8% to 12.4%).

Priced to move?
Compared to other superstar medications, Wegovy and Zepbound aren't necessarily expensive for some folks. Still, they can burn a hole in a wallet for a person or household on a modest budget without some form of support.

Wegovy's list price for a 28-day box is a shade over $1,349, while a similar supply of Zepbound can set a user back more than $1,250. Depending on the coverage of one's insurance or federal government assistance program (like Medicare) and eligibility, that figure can come down, at times to $0.

Manufacturer self-pay programs also provide eligible users a financial break. Specifically, $499 is the standard Novo Nordisk rate for its Wegovy initiative, and it's either $349 or $499 for Zepbound under Eli Lilly's LillyDirect, depending on dosage.

In the White House's official statement on the Novo Nordisk/Eli Lilly deal, an  essentially one-month supply of Wegovy (and its sister medication indicated for diabetes, Ozempic) is to cost $350 when bought through TrumpRx, which is not yet up and running. Zepbound -- and Eli Lilly's next-generation investigational obesity/diabetes drug orforglipron, if and when approved -- would sell for an average of $346.

The Medicare prices of Wegovy, Ozempic, Zepbound, and Mounjaro (basically Zepbound approved for diabetes) will each be $245. Eligible patients in the program will fork over a copay of $50 for the drug of their choice.

Attractive discounting
That's a lot of numbers, so let's try digesting them into a single observation. The prices set by the executive branch with Novo Nordisk and Eli Lilly are clearly advantageous as advertised, but only to those who lack decent coverage from private or government-sponsored healthcare insurance.

Theoretically, this is a wonderful way to get the likes of Wegovy and Zepbound into the hands of the less prosperous. Such an effort should go some distance toward democratizing pharmaceutical-assisted weight loss in an America that needs to shed pounds.

The Trump administration, however, has shown a tendency to waver in some of its policy efforts -- for evidence, we don't have to look much further than its clutch of stop-and-start, up-and-down tariffs of late. TrumpRx could suffer from the same dynamic, and in the worst-case scenario not get off the ground at all.

Open questions
If it does, though, it's sure to ramp up the still-considerable demand for weight loss products. So yes, both Novo Nordisk and Eli Lilly should reap the benefits from this if everything goes according to plan, but bear in mind their margins will be smaller due to those beneficial prices.

How much could this increase demand from an already budget-squeezed population? And to what extent would this change affect sales volume and margins? These are questions we don't yet have enough information on to form good estimates. The proof, as they say, will be in the pudding.

What any investor in, or observer of, the two companies should watch is adjustments to guidance in their quarterly earnings reports. They're likely to be revised by their finance teams soon before and following the TrumpRx rollout, if that happens. It would also be wise to keep an eye on potential analyst revisions to their takes on the two stocks inspired by the same development(s).

As of now, though, since there are more questions than answers in this situation, I wouldn't base any Novo Nordisk or Eli Lilly investment decision on the two companies' involvement in TrumpRx, which, don't forget, is still in the planning stage.

About Yahoo Finance: Yahoo Finance provides free stock ticker data, up-to-date news, portfolio management resources, comprehensive market data, advanced tools, and more information to help you manage your financial life. - Get the latest news and data at finance.yahoo.com - Download the Yahoo Finance app on Apple (https://apple.co/3Rten0R) or Android (https://bit.ly/3t8UnXO) - Follow Yahoo Finance on social: X: http://twitter.com/YahooFinance Instagram: https://www.instagram.com/yahoofinance/?hl=en TikTok: https://www.tiktok.com/@yahoofinance?lang=en Facebook: https://www.facebook.com/yahoofinance/ LinkedIn: https://www.linkedin.com/company/yahoo-finance

What happenedAccording to a filing with the Securities and Exchange Commission dated November 14, 2025, investment management firm Seldon Capital LP disclosed a new position in ACM Research (ACMR 3.49%), adding 193,242 shares.

The estimated value of this position at quarter-end was $7.56 million, based on the reported holding as of September 30, 2025. The fund reported 70 total positions for the period.

What else to knowThis is a new position, representing 2.66% of Seldon Capital's 13F AUM.

Top holdings after the filing: 

TLN: $30.14 million (10.6% of AUM)VT: $29.37 million (10.3% of AUM)CLS: $27.58 million (9.7% of AUM)VTI: $17.75 million (6.2% of AUM)ECH: $11.15 million (3.9% of AUM)As of November 14, 2025, shares of ACM Research were priced at $31.51, and the one-year total return was 68.2%. The stock outperformed the S&P 500 by 57 percentage points.

Company OverviewMetricValuePrice (as of market close November 14, 2025)$31.51Market capitalization$2.12 billionRevenue (TTM)$880.35 millionNet income (TTM)$117.11 millionCompany SnapshotACM Research develops and sells single-wafer wet cleaning equipment, electro-chemical plating systems, and advanced cleaning technologies for semiconductor manufacturing.The company sells proprietary equipment and technology solutions to integrated circuit manufacturers through a direct sales force and third-party representatives.ACM Research sells single-wafer wet cleaning equipment for manufacturing integrated chips worldwide.ACM Research is a leading provider of advanced wafer processing equipment for the semiconductor industry, specializing in single-wafer cleaning and plating technologies. The company leverages proprietary innovations such as space alternated phase shift and timely energized bubble oscillation to address the needs of cutting-edge chip fabrication.

With a global customer base and a focus on enhancing manufacturing yields, ACM Research positions itself as a key enabler of next-generation semiconductor production.

Foolish takeSeldon Capital's purchase of ACM Research stock is noteworthy because it's a new position, and it was of substantial size, bringing ACM shares to 2.7% of AUM. This suggests Seldon Capital holds a bullish outlook towards the company.

The buy in the third quarter was prescient as ACM Research shares hit a 52-week high of $45.12 in October. The rise in stock price is understandable given ACM's excellent business performance.

In Q3, sales rose a strong 32% year over year to $269.2 million. The company expects full-year revenue to come in between $875 million and $925 million. This represents excellent growth over 2024's $782.1 million.

ACM Research's diluted earnings per share (EPS) is also rising year over year. Through the first three quarters of 2025, its diluted EPS was $1.26 compared to $1.07 in 2024.

With its outstanding performance, ACM Research looks like a solid investment in the hot semiconductor industry.

GlossaryNew position: When an investor or fund buys shares of a company for the first time.
Assets under management (AUM): The total market value of investments managed by a fund or financial institution.
13F: A quarterly SEC filing required from institutional investment managers to disclose their equity holdings.
Reportable assets: Investments that must be disclosed in regulatory filings, such as those included in a 13F report.
Total return: The investment's price change plus all dividends and distributions, assuming those payouts are reinvested.
Outperformed: Achieved a higher return than a specified benchmark or index over a given period.
Market close: The end of the regular trading session for a stock exchange on a given day.
Proprietary equipment: Technology or products owned and developed by a specific company, not available to competitors.
Integrated circuit manufacturers: Companies that design and produce semiconductor chips used in electronic devices.
Single-wafer wet cleaning equipment: Machines that clean individual semiconductor wafers using liquid chemicals during chip manufacturing.
Space alternated phase shift: A specialized technology used to improve semiconductor wafer processing efficiency and precision.
TTM: The 12-month period ending with the most recent quarterly report.

Robert Izquierdo has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Celestica and Vanguard Total Stock Market ETF. The Motley Fool has a disclosure policy.

Tower Semiconductor's Q3 report arrived with promising signs for investors.

Tower Semiconductor (TSEM +0.17%) stock surged in this week's trading thanks to a better-than-expected quarterly report. The analog chip company's share price gained 18.1% over the stretch.

Despite bearish momentum for chip stocks and a 0.5% decline for the Nasdaq Composite over the last week, Tower Semiconductor stock managed to rally. With its recent pop, the company's share price is now up 93% across 2025's trading.

Image source: Getty Images.

Tower Semiconductor soared thanks to Q3 beats
Tower Semiconductor published its Q3 results after the market closed last Monday and served up results that exceeded Wall Street's targets. The business's earnings per share of $0.47 in the quarter beat the average analyst estimate by $0.02, and sales of $396 million topped the target forecast by $1 million.

Today's Change

(

0.17

%) $

0.17

Current Price

$

99.26

Revenue in the quarter was up 7% year over year, and gross profit improved to $93 million -- up from $80 million in the prior-year period. Meanwhile, operating cash flow came in at $139 million -- good for a margin of 31.6%.

What's next for Tower Semiconductor?
For the fourth quarter, Tower Semiconductor's midpoint guidance calls for sales of $440 million. Hitting that target would mean posting annual growth of 14% and sequential quarterly growth of 11%.

Tower's growth cycle has historically been subject to cyclical trends, and guidance for accelerating growth in the current quarter is an encouraging sign. The company is now seeing growth across all of its core product segments -- power management, image sensors, and 65nm RF mobile. Even better for investors, Tower is seeing rising demand from artificial intelligence (AI) data centers.

Keith Noonan has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

The iShares Core High Dividend ETF (HDV +0.25%) and the Schwab U.S. Dividend Equity ETF (SCHD +0.07%) both focus on U.S. dividend stocks, but SCHD stands out for its lower cost, higher yield, and much larger assets under management, while HDV has shown stronger recent returns.

Both the iShares Core High Dividend ETF and the Schwab U.S. Dividend Equity ETF aim to deliver consistent dividend income from U.S. equities, but they differ in stock selection and weighting approaches. This comparison explores how their fees, size, sector exposure, performance, and risk stack up for investors considering a U.S. dividend ETF.

Snapshot (cost & size)MetricHDVSCHDIssuerISharesSchwabExpense ratio0.08%0.06%1-yr return (as of Nov. 14, 2025)3.6%(5.7%)Dividend yield3.1%3.8%AUM$11.6 billion$70.1 billionBeta measures price volatility relative to the S&P 500; beta is calculated from five-year weekly returns. The 1-yr return represents total return over the trailing 12 months.

SCHD is slightly more affordable, with a 0.06% expense ratio compared to HDV’s 0.08%, and it also offers a higher dividend yield of 3.8% versus HDV’s 3.1%, which may appeal to income-focused investors.

Performance & risk comparisonMetricHDVSCHDGrowth of $1,000 over 5 years$1,400$1,300What's insideSCHD tracks a portfolio of 103 U.S. dividend payers, with significant exposure to energy (20%), consumer defensive (18%), and healthcare (16%) sectors. Top holdings include Amgen (AMGN +0.22%), Abbvie (ABBV +0.03%), and Cisco Systems (CSCO +0.81%). The fund has a 14.1-year track record and is one of the most popular U.S. dividend ETFs by assets under management.

HDV selects 75 stocks, with an even heavier tilt to consumer defensive (25%), energy (22%), and healthcare (20%). Its largest positions are Exxon Mobil (XOM +1.30%), Johnson & Johnson (JNJ +0.38%), and Chevron (CVX +1.31%). Both funds avoid leverage, currency hedging, and other structural quirks, but their sector weights and top holdings show subtle differences.

For more guidance on ETF investing, check out the full guide at this link.

Foolish takeThe Schwab U.S. Dividend Equity ETF and the iShares Core High Dividend ETF both offer exposure to dividend-paying stocks, but the returns they've provided haven't been the same. The Schwab US Dividend Equity ETF delivered a total return of 199.5% over the past 10 years. The iShares Core High Dividend ETF underperformed with a total return of just 143.1% over the past decade.

Income-seeking investors who bought shares of the iShares Core High Dividend ETF have been more than a little disappointed with the growth of their payouts. Its latest quarterly payment was just 2.85% higher than the payment it issued five years ago. This ETF tracks the Morningstar Dividend Yield Focus Index.

The Schwab U.S. Dividend Equity ETF tracks the Dow Jones U.S. Dividend 100 Index, which is more focused on dividend growth and sustainability. The focus on dividend growers helped its dividend payout rise by 29.9% over the past five years.

Investors seeking a pure focus on high yields at the moment might find the iShares Core High Dividend ETF more to their liking. If maximizing your returns over the long run is your main goal, though, the Schwab U.S. Dividend Equity ETF is the better option.

GlossaryETF: Exchange-traded fund; a pooled investment fund traded on stock exchanges like a stock.
Expense ratio: The annual fee, as a percentage of assets, that a fund charges its investors.
Dividend yield: Annual dividends paid by a fund or stock divided by its current price, expressed as a percentage.
Assets under management (AUM): The total market value of assets that a fund manages on behalf of investors.
Beta: A measure of a fund's volatility compared to the overall market, typically the S&P 500.
Max drawdown: The largest observed percentage drop from a fund's peak value to its lowest point over a period.
Sector exposure: The proportion of a fund's assets invested in specific industry sectors, such as energy or healthcare.
Track record: The length of time a fund has been operating, used to assess its historical performance.
Leverage: The use of borrowed money to increase the potential return of an investment.
Currency hedging: Strategies used by funds to reduce the impact of currency fluctuations on returns.
Total return: The investment's price change plus all dividends and distributions, assuming those payouts are reinvested.
Weighting: The method a fund uses to determine how much of each asset it holds in its portfolio.

NEW YORK, Nov. 16, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of KBR, Inc. (NYSE: KBR) between May 6, 2025 and June 19, 2025, both dates inclusive (the “Class Period”), of the important November 18, 2025 lead plaintiff deadline in the securities class action first filed by the Firm.

SO WHAT: If you purchased KBR securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the KBR class action, go to https://rosenlegal.com/submit-form/?case_id=42136 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 18, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made materially false and/or misleading statements and/or failed to disclose that: (1) despite the knowledge that the U.S. Department of Defense’s Transportation Command (TRANSCOM) had, for months, had material concerns with HomeSafe’s ability to fulfill the Global Household Goods Contract, defendants claimed that the partnership was without issue, and would ramp up in future quarters; and (2) as a result, defendants’ statements about KBR’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the KBR class action, go to https://rosenlegal.com/submit-form/?case_id=42136 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686-1060
        Toll Free: (866) 767-3653
        Fax: (212) 202-3827
        [email protected]
        www.rosenlegal.com

BitMEX co-founder Arthur Hayes transferred $2.5 million worth of Ethereum and ecosystem tokens to institutional market makers including Flowdesk, FalconX, and Wintermute.

Blockchain analyst EmberCN reported the moves and questioned whether Hayes is selling assets to add to his Zcash position.

Hayes has been vocal about his ZEC (ZEC) holdings during the recent privacy coin rally. On November 15, he posted, “This chart is just so strong I aped more. $ZEC” on X and suggested that he increased his position after the token’s 700% surge since October.

X post by analyst EmberCN
Arthur Hayes transfers ETH and ecosystem tokens worth $2.5M
EmberCN tracked multiple transfers from Hayes’ wallet to institutional trading platforms. The BitMEX co-founder moved 520 ETH (ETH) worth $1.66 million, 2.624 million ENA (ENA) tokens valued at $730,000, and 132,000 ETHFI worth $120,000 to the market makers.

Hayes also tested a transfer of 10 LDO (LDO) tokens to FalconX about 50 minutes after the initial transactions. EmberCN noted that Hayes “should continue selling LDO soon.”

According to follow-up reports, Hayes sold 260 ETH worth around $820,000, 2.40 million ENA tokens at $657,000, 640,000 LDO at $480,000, 1,630 AAVE (AAVE) at $290,000, and 28,670 UNI (UNI) at $211,000. The total value of these sales reached roughly $2.45 million.

The analyst questioned whether Hayes is converting these assets into Zcash. “Is this selling coins to add to $ZEC? He’s been crazily pumping ZEC during this period,” EmberCN wrote.

Maelstrom CIO calls ZEC superior to XRP
Hayes has made several bullish statements about Zcash in recent weeks. He declared “ZEC > XRP,” suggesting Zcash could surpass Ripple in market capitalization.

The Maelstrom Fund CIO predicted Zcash could reach between $10,000 and $20,000 per coin. He targeted a ZEC/BTC pair price of 0.2, which would translate to approximately $19,200 for ZEC.

Hayes revealed that Zcash has become Maelstrom’s second-largest liquid holding after Bitcoin. He described Zcash as “Bitcoin with full privacy” and suggested ZEC could reach 10% to 20% of Bitcoin’s value in the current market cycle.

In mid-November, Hayes urged ZEC holders to withdraw tokens from centralized exchanges. “If you hold $ZEC on a CEX, withdraw it to a self-custodial wallet and shield it,” he posted.

Nov 16, 2025 at 16:30 // Price

The price of TRON has been prevented from falling below the moving average lines by support at the 50-day SMA.

TRX price long-term forecast: bearish

A break below the 50-day SMA support would signal the continuation of selling pressure. However, the cryptocurrency has dropped from a high of $0.368 to a low of $0.276. According to projections, TRON price will continue its downward trend.

On September 1, a candle body retraced and approached the 38.2% Fibonacci retracement line. The upward correction suggests that TRX will fall to the 2.618 Fibonacci extension level, or a low of $0.184. At the time of writing, the altcoin is valued at $0.292.

Technical Indicators 

Key Resistance Zones: $0.40, $0.45, and $0.50 

Key Support Zones: $0.20, $0.15, and $0.10

TRX price indicator analysis

The weekly chart shows that the price bars have fallen between the moving average lines. On the downside, if the cryptocurrency falls below its 50-day SMA support, selling pressure will resume.

On the upside, a break above the 21-day SMA would allow the cryptocurrency to resume its upward trajectory. On the 4-hour chart, the price bars are above the upward-sloping moving average lines.

What is the next move for TRON?

TRON has dropped below the moving average lines on the 4-hour chart. The cryptocurrency price is trading above the $0.29 support level but below the moving average lines. Today, the 50-day SMA barrier rejected the upward correction. TRON will continue to fall if the $0.29 support level is broken.

Disclaimer. This analysis and forecast are the personal opinions of the author. The data provided is collected by the author and is not sponsored by any company or token developer. This is not a recommendation to buy or sell cryptocurrency and should not be viewed as an endorsement by Coinidol.com. Readers should do their research before investing in funds.

Ripple’s XRP is still trading inside a sustained downward structure, with each recovery attempt meeting supply. The latest rejection near the $2.45–$2.55 resistance keeps the broader bearish leg valid, while the higher-timeframe demand at $2.05–$2.15 remains the key zone separating a controlled correction from a deeper sell-off.

XRP Price Analysis
By Shayan

The Daily Chart
On the daily timeframe, Ripple’s token continues to trade within a large descending channel formation, a structure that often precedes bullish reversals when supported by volume expansion. After rebounding from the $2.1–$2.2 demand zone, the price has reclaimed ground toward $2.5, aligning with a crucial supply zone (order Block) and close to the 200-day moving average, while the 100-day MA remains slightly overhead near $2.7.

This confluence represents a critical resistance cluster, combining dynamic resistance (MAs), a prior supply block, and the wedge’s structural ceiling. A daily close above $2.6 would mark a potential breakout confirmation, shifting market structure in favor of buyers and paving the way toward the $2.8–$3.1 macro supply range.

However, failure to break this level could lead to another rejection, keeping XRP inside its mid-term descending pattern and possibly triggering a retest of the $2.3–$2.2 support zone. RSI has broken above the midline, signaling recovering momentum, yet sustained strength will depend on confirmation from price action and volume expansion through resistance.

The 4-Hour Chart
On the 4-hour chart, XRP continues to track within a clean descending channel, with well-defined lower highs and lower lows shaping its short-term market structure. The most recent rally into the $2.45–$2.55 rejection zone aligned perfectly with the channel’s midline, confirming its role as an active seller’s base.

Following the rejection, the price slid back toward the $2.20–$2.25 region, where a soft reaction occurred, though momentum remains weak. The dotted internal trendline from the earlier breakdown continues to serve as intraday resistance, preventing bullish continuation attempts.

The broader characteristic of this chart is compression. The price is drifting lower within the channel, but volatility is contracting, indicating that sellers are losing strength while buyers are selectively accumulating at the bottom boundary.

This type of price action often precedes a larger expansion move, but the direction will depend entirely on whether XRP breaks above the descending trendline (bullish) or falls below the $2.15 support (bearish).

A sweep into the lower boundary near $2.05 followed by a sharp reversal would fit the textbook model of a final liquidity grab before a corrective bounce. Conversely, losing this level would likely accelerate the downtrend into the deeper $1.75 liquidity pocket.

Tags:

In a twist to the ongoing investigations surrounding Jeffrey Epstein, recently unveiled emails have spotlighted conversations about Bitcoin that took place in his Manhattan townhouse. Participants in these discussions included notable figures such as Tether co-founder Brock Pierce and former U.S. Treasury Secretary Larry Summers.

Sun, 16/11/2025 - 16:46

Dogecoin closed the week in the red, marking three straight weeks of decline. The Dogecoin official X account injects fun amid boring market activity.

Cover image via U.Today

Disclaimer: The opinions expressed by our writers are their own and do not represent the views of U.Today. The financial and market information provided on U.Today is intended for informational purposes only. U.Today is not liable for any financial losses incurred while trading cryptocurrencies. Conduct your own research by contacting financial experts before making any investment decisions. We believe that all content is accurate as of the date of publication, but certain offers mentioned may no longer be available.

The majority of cryptocurrencies, including Dogecoin, are trading down early Sunday session.

At the time of writing, Dogecoin was down 1.41% in the last 24 hours to $0.16, extending a downturn that saw Bitcoin close its worst week since March.

Dogecoin fell for four consecutive days spanning from Tuesday to Friday to mark a red week, closing the week down 10.49%, according to TradingView data.

HOT Stories

The crypto market remains under strain after $19 billion in liquidations in Oct. 10's flash crash wiped out over $1 trillion from the total market value of all cryptocurrencies.

Liquidations in long positions have been significant, with open interest in crypto futures struggling to recover since the market crash in early October. The Fear and Greed Index is at 18, indicating "extreme fear," which demonstrates increasing expectations for further sell-offs.

What a DOGE do?Amid the current sentiment in the market, Dogecoin in its usual lighthearted manner intended to inject a little bit of fun as it tweeted via its official X account: "It weekemd. What a DOGE do?"

Dogecoin's lighthearted and humorous nature perfectly aligns with its ethos as a fun currency. Its playful nature and grassroots origins have endeared it in the crypto market, now ranking as the ninth largest cryptocurrency with a market cap of $24.4 billion.

Notable buzz has of late revolved around Dogecoin; Elon Musk recently posted a picture of a Shiba Inu, Dogecoin’s mascot. In an X post, Musk posted a meme of a Shiba Inu playing a banjo.

House of Doge partner 21Shares recently launched two top 10 crypto index ETFs that included DOGE, with potential Dogecoin news in relation to 21Shares to be announced in the days ahead.

Related articles

The crypto market had big expectations for XRP this week, but reality delivered something messier. After Canary Capital's XRPC ETF crushed day-one records with $58 million in trading volume and $245 million in inflows on November 13, XRP looked poised for a breakout. Instead, the token stumbled hard, losing 4.3% to plunge from $2.

Trusted Editorial content, reviewed by leading industry experts and seasoned editors. Ad Disclosure

Bitcoin has enjoyed attention as one of the most rewarding stores of value in recent years, with institutional adoption reaching new highs this year. One such landmark Bitcoin acquisition was made by Harvard University, arguably the world’s most prestigious academic institution.

Earlier in August, Harvard disclosed an investment portfolio containing $117 million worth of shares in BlackRock’s spot Bitcoin exchange-traded fund (ETF) as of the end of Q2. According to its latest disclosure, the university’s BTC exposure nearly tripled over the last quarter.

BlackRock’s IBIT Becomes Harvard’s Largest Investment
In its latest 13F filing, Harvard University revealed that it held 6,813,612 shares of BlackRock’s iShares Bitcoin Trust (IBIT) valued at approximately $443 million as of September 30. 

This additional acquisition highlights the institution’s expansive capital allocation strategy, which also saw its SPDR Gold Trust (GLD) holdings grow to 661,391 shares (worth approximately $235 million) in 2025 Q3.

Notably, Harvard’s current holding of the leading spot BTC ETF represents a 257% increase from the disclosed 1,906,000 shares declared as of June. As of now, BlackRock’s exchange-traded fund is the single largest investment of the university’s reported holdings.

While the current IBIT position makes only a small portion of Harvard’s endowment of $57 billion, it is significant enough to make the university the 16th-largest IBIT holder. As inferred earlier, stories of institutional adoption such as this further add credence to Bitcoin’s status as a strategic reserve asset and the growing demand for exchange-traded funds.

Bloomberg ETF analyst Eric Balchunas wrote on X:

It’s super rare/difficult to get an endowment to bite on an ETF- esp a Harvard or Yale, it’s as good a validation as an ETF can get. That said, half a billion is a mere 1% of total endowment. Big enough to rank 16th among IBIT holders tho.

BlackRock Bitcoin ETF Records Its Largest Outflow Day
The US-based Bitcoin ETFs have suffered waning investor demand in recent weeks, with the past week particularly disappointing. According to the latest market data, the exchange-traded funds registered a total net outflow of $1.1 billion in the past week.

Leading these withdrawals was BlackRock’s iShares Bitcoin Trust, which is currently on a three-day outflow streak. Data from SoSoValue shows that $463.1 million flowed out of the BTC ETF on Friday, November 14.

As of this writing, BlackRock’s IBIT still ranks as the largest spot Bitcoin ETF, with net assets worth roughly $74.98 billion.

The price of BTC on the daily timeframe | Source: BTCUSDT chart on TradingView
Featured image from Rick Friedman/AFP via Getty Images, chart from TradingView

Editorial Process for bitcoinist is centered on delivering thoroughly researched, accurate, and unbiased content. We uphold strict sourcing standards, and each page undergoes diligent review by our team of top technology experts and seasoned editors. This process ensures the integrity, relevance, and value of our content for our readers.

Sign Up for Our Newsletter!
For updates and exclusive offers enter your email.

Opeyemi Sule is a passionate crypto enthusiast, a proficient content writer, and a journalist at Bitcoinist. Opeyemi creates unique pieces unraveling the complexities of blockchain technology and sharing insights on the latest trends in the world of cryptocurrencies. Opeyemi enjoys reading poetry, chatting about politics, and listening to music, in addition to his strong interest in cryptocurrency.

Futures traders jumped in after the banking charter, but whale-side selling kept sentiment on thin ice.

18h05 ▪
4
min read ▪ by
James G.

Summarize this article with:

Growing interest in digital assets is prompting investors to reassess which tokens deserve long-term attention. Recent shifts in sentiment around Solana, XRP, and other major networks reflect a market still trying to determine its next set of leaders.

In brief

Solana solidifies its lead for the third crypto spot, driven by strong inflows and rising interest beyond Bitcoin and Ethereum.
XRP pushes for relevance with a standout ETF launch, though investor doubts remain around its long-term network activity and adoption.
Institutional confidence persists as ETF volumes hit $4.07B, signaling steady engagement despite redemptions across asset classes.
Investors await clearer product-market fit from emerging networks, fueling competition for leadership beyond the top two assets.

Solana Pulls Ahead in the Race for Crypto’s Next Spot
Investors generally continue to view Bitcoin as the core holding, with Ethereum following closely behind. According to Coinbase Asset Management president Anthony Bassili, most market participants agree on these two anchors, but confidence drops once the discussion turns to which asset should come next.

There’s a very, very clear view in the investor community in terms of the right first portfolio is Bitcoin. The market is very unsure as to what’s the next asset they want to own after that.

Anthony Bassili
Bassili said Solana is “maybe” the third asset on investors’ radar, supported by consistent inflows into SOL-linked funds. On November 5, SOL products attracted another $9.7 million, extending a seven-day streak and bringing total net additions since launch to $294 million. 

Interest in alternative Layer-1 networks is increasing, even as Bitcoin and Ethereum products experience steady outflows.

Bassili Sees Solana Firm in Third Place While XRP Struggles to Close the Gap
Bassili mentioned that after Solana, a “very wide gap” separates it from the next group of contenders, with XRP sitting just beyond that line. Investor hesitation, he noted, stems from uncertainty about long-term network activity and how each protocol might operate within broader liquidity systems.

Amid these shifts, several factors appear to be shaping investor choices:

Confidence remains highest in assets with established historical demand.
Interest in the third spot is leaning toward Solana due to recent inflows.
XRP is gaining momentum but still shows limited network activity.
ETF volumes indicate steady participation despite short-term redemptions.
The market is waiting for clearer evidence of real product-market fit from newer networks.

ETF activity suggests that institutional interest remains intact. Total trading volume recently reached $4.07 billion, indicating sustained engagement even with redemptions across several crypto categories. Long-term net inflows remain solid, and participation continues to widen compared with previous years.

XRP Pushes for “Fourth Spot” as New ETF Sets 2025’s Strongest Debut
Bassili said the “fourth position” is still open and will likely go to the network or application that can demonstrate clear and repeatable use cases. XRP is working toward that goal. Canary Capital’s XRP ETF closed its first day with $58 million in trading volume, marking the strongest ETF launch of 2025 across both crypto and traditional products.

Ripple has also been active on the corporate side, adding a custodian, a stablecoin orchestration layer, and a broker-dealer to its structure. Bassili described these steps as constructive, though he noted that markets can shift quickly once investors pay closer attention to cash flows rather than narratives.

He added that asset prices can change quickly once valuations meet real economic conditions, adding another layer of uncertainty to the search for crypto’s next major contender.

Maximize your Cointribune experience with our "Read to Earn" program! For every article you read, earn points and access exclusive rewards. Sign up now and start earning benefits.

Join the program

A

A

Lien copié

James G.

James Godstime is a crypto journalist and market analyst with over three years of experience in crypto, Web3, and finance. He simplifies complex and technical ideas to engage readers. Outside of work, he enjoys football and tennis, which he follows passionately.

DISCLAIMER

The views, thoughts, and opinions expressed in this article belong solely to the author, and should not be taken as investment advice. Do your own research before taking any investment decisions.

Cover image via U.Today

Disclaimer: The opinions expressed by our writers are their own and do not represent the views of U.Today. The financial and market information provided on U.Today is intended for informational purposes only. U.Today is not liable for any financial losses incurred while trading cryptocurrencies. Conduct your own research by contacting financial experts before making any investment decisions. We believe that all content is accurate as of the date of publication, but certain offers mentioned may no longer be available.

The end of the week is controlled by bears, according to CoinMarketCap.

Top coins by CoinMarketCapETH/USDThe rate of Ethereum (ETH) has declined by 1.03% over the last 24 hours.

Image by TradingViewOn the hourly chart, the price of ETH is closer to the support than to the resistance level. If the daily bar closes near $3,131, the decline is likely to continue to the $3,100 zone shortly.

Image by TradingViewA similar picture is on the bigger time frame. If a breakout of the $3,000 area happens, the accumulated energy might be enough for a test of the $2,857 support.

You Might Also Like

Such a scenario is relevant until the end of the month.

Image by TradingViewFrom the midterm point of view, one should focus on the weekly candle closure in terms of the $2,857 mark. If a false breakout happens, buyers may seize the initiative, which may lead to a bounce back to the $3,000-$3,200 range.

Ethereum is trading at $3,174 at press time.

Cover image via U.Today

Disclaimer: The opinions expressed by our writers are their own and do not represent the views of U.Today. The financial and market information provided on U.Today is intended for informational purposes only. U.Today is not liable for any financial losses incurred while trading cryptocurrencies. Conduct your own research by contacting financial experts before making any investment decisions. We believe that all content is accurate as of the date of publication, but certain offers mentioned may no longer be available.

Bears are controlling the situation on the market on the last day of the week, according to CoinStats.

DOGE chart by CoinStatsDOGE/USDThe price of DOGE has fallen by 1.48% since yesterday.

Image by TradingViewOn the hourly chart, the rate of DOGE is near the local support of $0.1599. If buyers cannot seize the initiative and a breakout happens, the correction is likely to continue to the $0.1580 range.

Image by TradingViewSellers are also more powerful than buyers on the bigger time frame. However, the price of the meme coin is far from the main levels at the moment.

You Might Also Like

The volume is low, which means ongoing sideways trading is the more likely scenario over the next few days.

Image by TradingViewFrom the midterm point of view, there are no reversal signals so far. If the weekly bar closes around the current prices or below, the drop may lead to a test of the $0.12-$0.14 range soon.

DOGE is trading at $0.1614 at press time.

ADA is down by 5.5% daily, XRP by more than 3%.

The cryptocurrency market is heading south again on Sunday afternoon, and two of the largest and most popular altcoins – ADA and XRP – are no exception.

Both assets have turned red once again, only continuing the recent trend that began in the middle of the previous business week. Whales could be to blame this time.

ADA Whales Sell
Data shared by Ali Martinez indicates that Cardano whales have been selling tokens en masse. More precisely, they disposed of 440 million ADA in the past month, which has increased the immediate selling pressure on the asset.

440 million Cardano $ADA have been sold by whales in just one month! pic.twitter.com/KHwk1XguZk

— Ali (@ali_charts) November 16, 2025

Within this timeframe, the asset’s price has dropped by over 23%. The past week has been particularly painful, as it has plummeted by 17% since last Sunday. On a daily scale, ADA is down by 5.5% and now sits below $0.48, which is the lowest price tag since the early October massacre.

The analyst with over 160,000 followers on X gave some hope to ADA investors, asserting that the TD Sequential, a metric used to determine a particular asset’s exhaustion in either direction, had flashed a buy signal. The indicator previously flagged ADA’s top and could now suggest that a larger rebound is about to take place.

XRP Situation Worse
The landscape around XRP is even more worrisome. Ripple whales have been selling massive portions of the asset for over a month. At one point, CryptoPotato reported that they had offloaded 1.4 billion tokens within a 30-day period.

You may also like:

After XRPC, the Race Is On: Which XRP ETF Will Hit the Market Next?

Canary’s XRP ETF (XRPC) Launch Successful: Here’s What Happened on Day 1

XRP Leads the Fear Trade as BTC and ETH Sentiment Weakens

Their selling spree has continued during and after the Friday market-wide crash. Additional data from Martinez shows that they dumped another 200 million tokens, worth over $400 million at today’s prices.

Whales dumped nearly 200 million $XRP in just 48 hours! pic.twitter.com/4qObRnDE0X

— Ali (@ali_charts) November 16, 2025

Somewhat expected, this growing selling pressure from large market participants has harmed the underlying asset’s price, which is down by 4% in the past 24 hours alone (7% weekly) and now trades well below $2.20.

Martinez brought up something positive for the XRP Army as well, though. He noted earlier today that the number of whale transactions hit 716 daily, each worth more than $1 million. This is the highest count in four months, and suggests that the overall interest in the asset is spiking.

This could be due to the recent launch of a spot XRP ETF in the United States, which broke the record for first-day trading volume for this year.

Tags:

Despite its bearish reputation, every death cross in the current cycle has marked a major local bottom. Nov 16, 2025, 5:39 p.m.

Glassnode data shows that bitcoin’s "death cross," a technical analysis term that may indicate a bearish signal, is imminent, but with a catch.

The 50-day moving average for bitcoin at $110,669 is now on the verge of slipping below the 200-day moving average at $110,459, potentially triggering the death cross. This crossover is widely viewed in technical analysis as a bearish signal because it reflects weakening short-term momentum relative to the longer trend.

STORY CONTINUES BELOW

However, this can also act as a possible positive signal.

Bitcoin is currently down about 25% from its October all time high around $126,000 and this correction has been ongoing for roughly 41 days. Despite the reputation of the death cross, this would be the fourth occurrence of the death cross since the cycle started back in 2023 and each previous instance has aligned with a major local bottoms.

In September 2023, bitcoin bottomed near $25,000, in August 2024 during the yen carry trade unwind it found support around $49,000, and then in April 2025, during uncertainty around President Trump’s tariff policy, BTC bottomed below $75,000.

In the current setup, bitcoin has fallen to $94,000 and in all four prior instances the market put in its low just before the death cross formed, raising the question of whether the same pattern may be unfolding again.

Is this time different?This current drawdown is less severe than the April correction, when bitcoin dropped below $75,000 during the tariff related turmoil.

The April correction was both deeper and longer than the current correction, with bitcoin falling about 30% from the January peak near $109,000 and spending around 79 days trending lower before bottoming in the first week of April. With current selloff of 25% and 41 days, perhaps further downside still possible.

However, the broader environment now includes the end of the United States government shutdown on Nov. 12. The closest comparison is the 2019 shutdown, when bitcoin fell more than 9% five days after the government reopened on Jan. 25 2019.

It took until Feb. 9 2019 for bitcoin to recover, approximately two weeks.

BTC Price Action during US government re-opening in 2019 (Tradingview)

This time around bitcoin has already dropped as much as 10% since the reopening. The question now is whether the same pattern will play out again.

More For You

Protocol Research: GoPlus Security

Nov 14, 2025

What to know:

As of October 2025, GoPlus has generated $4.7M in total revenue across its product lines. The GoPlus App is the primary revenue driver, contributing $2.5M (approx. 53%), followed by the SafeToken Protocol at $1.7M.GoPlus Intelligence's Token Security API averaged 717 million monthly calls year-to-date in 2025 , with a peak of nearly 1 billion calls in February 2025. Total blockchain-level requests, including transaction simulations, averaged an additional 350 million per month.Since its January 2025 launch , the $GPS token has registered over $5B in total spot volume and $10B in derivatives volume in 2025. Monthly spot volume peaked in March 2025 at over $1.1B , while derivatives volume peaked the same month at over $4B.View Full Report

More For You

Tom Lee Says Ether Is Entering a Bitcoin-Like 'Supercycle'; Critics Push Back

24 minutes ago

BitMine Immersion Technologies’ executive chairman says ETH is beginning a bitcoin-style run as he highlights past drawdowns and patience.

What to know:

Tom Lee says ETH is starting a BTC-like supercycle and urges patience through volatility.SSkeptics question Ethereum's unique utility and defensibility versus rival chains.Read full story

Seldon Capital purchased about 6.1 million shares of Lithium Argentina.

Seldon Capital LP disclosed a new position in Lithium Argentina AG (NYSE: LAR) on Nov. 14, with a value of $6.1 million at quarter end.

Initiated new holding of 1.8 million shares worth $6.1 million as of Sept. 30.Position represents 2.1% of 13F reportable assets under managementIt's not among the fund’s top five holdings by valueWhat happenedSeldon Capital LP filed its quarterly Form 13F with the U.S. Securities and Exchange Commission on Nov. 14, revealing a new stake in Lithium Argentina AG (NYSE: LAR). The fund acquired 1.8 million shares, marking an estimated $6.1 million addition based on quarter-end values. The position accounts for 2.1% of the firm’s $284.5 million in reportable U.S. equity assets. SEC filing.

What else to knowThis is a new position, representing 2.1% of Seldon Capital LP's 13F assets under management as of Sept. 30.Top holdings from the filing:  NASDAQ: TLN: $30.14 million (10.6% of AUM)NYSEMKT: VT: $29.37 million (10.3% of AUM)NYSE: CLS: $27.58 million (9.7% of AUM)NYSEMKT: VTI: $17.75 million (6.2% of AUM)NYSEMKT: ECH: $11.15 million (3.9% of AUM)As of Nov. 14, 2025, shares of Lithium Argentina AG were priced at $4.47.The stock has gained 43.7% over the past year versus a 14.7 total return for the S&P 500.Company overviewMetricValuePrice (as of market close 2025-11-14)$4.47Market capitalization$725.80 millionNet income (TTM)($80.54 million)One-year price change43.73%Company snapshotLithium Argentina AG is a materials company focused on the exploration and development of lithium projects in Argentina. The company owns strategic assets in Jujuy and Salta provinces in Argentina. With headquarters in Switzerland and operations focused in South America, Lithium Argentina AG develops lithium projects for the international market.

Develops and advances lithium resource projects in Argentina, including the Cauchari-Olaroz and Pastos Grandes projects.Operates as a resource and materials company focused on lithium project development in Argentina.Serves global battery manufacturers and industrial clients seeking lithium for energy storage and electric vehicle applications.Foolish takeSeldon Capital quickly built a sizeable equity holding in Lithium Argentina. A new holding that the investment firm added during the third quarter, the position was valued at $6.1 million at the end of the third quarter. Among its 70 equity holdings, Lithium quickly became the 16th largest.

The company's lithium carbonate is used primarily in lithium-ion batteries and electric vehicles. Hence, its revenue generation is partly tied to renewable energy.

Seldon clearly believes in Lithium's potential since the company produced a scant $58 million in third-quarter revenue, and it lost $64.5 million. Lithium Argentina will need to scale the business, growing revenue and achieving economies of scale to achieve profitability.

GlossaryForm 13F: A quarterly report filed by institutional investment managers to disclose their equity holdings.
Assets under management (AUM): The total market value of investments managed on behalf of clients by a fund or firm.
Reportable assets: Investment holdings that must be disclosed in regulatory filings, such as the 13F report.
Position: The amount of a particular security or asset held in a portfolio.
Stake: The ownership interest or share held in a company by an investor or fund.
Initiated (new) holding: The first time a fund acquires shares in a particular company, creating a new position.
Quarter-end values: The value of holdings calculated as of the last day of the financial quarter.
Alpha: A measure of an investment's performance compared to a benchmark index, showing excess return.
Materials company: A business involved in extracting, processing, or developing raw materials, such as metals or minerals.
Resource projects: Initiatives focused on exploring or developing natural resources like minerals, oil, or gas.
TTM: The 12-month period ending with the most recent quarterly report.

Lawrence Rothman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Celestica. The Motley Fool has a disclosure policy.

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.